NCT00565448 / 2007-001211-33: Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents |
|
|
| Completed | 2 | 75 | Europe, RoW | docetaxel, Taxotere®, XRP6976, cisplatin, 5-fluorouracil, 5-FU | Sanofi | Nasopharyngeal Neoplasms, Carcinoma | 03/09 | 01/12 | | |
NCT01326559: Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC) |
|
|
| Completed | 2 | 33 | RoW | Docetaxel, Cisplatin, 5-FU and Cetuximab | Hong Kong Nasopharyngeal Cancer Study Group Limited, The University of Hong Kong, Sanofi, Merck Sharp & Dohme LLC, Roche Pharma AG | Nasopharyngeal Carcinoma | 12/16 | 03/17 | | |